Hoverink biotechnologies inc

Author: jovd

August undefined, 2024

Web23 de jan. de 2024 · Los Angeles, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will … WebLegal Name Hoverink Biotechnologies, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number (888)511-7358. Hoverink is a biopharmaceutical …

Hoverink Biotechnologies, Inc., today announced Hoverink

WebHOVERINK BIOTECHNOLOGIES, INC. EIN# 46-3590875. BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT AWARDS TO EXECUTIVES, … WebFind company research, competitor information, contact details & financial data for Hoverink Biotechnologies, Inc. of Los Angeles, CA. Get the latest business insights … originlab correlation plot

Cyrus Sajna - U.S. House of Representatives …

WebHoverink Biotechnologies, Inc. Street Address 1 Street Address 2; 1801 CENTURY PARK EAST: 24TH FLOOR: City State/Province/Country ZIP/PostalCode Phone Number of … WebOur mission is to improve the lives of patients who suffer from rare diseases for which there are... Los Angeles, Califórnia, Estados Unidos 90067 Web9 de nov. de 2024 · Contact Data Hoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California 90067 866-443-4666 [email protected] how to wine tasting

Hoverink Biotechnologies, Inc. SEC Registration

Hoverink Biotechnologies, Inc. (Form: S-1, Received: 11/02/2024 …

Web26 de set. de 2024 · Trademark Overview. On Wednesday, September 26, 2024, a trademark application was filed for KAIYADRU with the United States Patent and Trademark Office. The USPTO has given the KAIYADRU trademark a serial number of 88133141. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE … WebHoverink Biotechnologies, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Hoverink Biotechnologies, Inc.. how to wine tasteWeb20 de dez. de 2024 · Pre-Clinical Trials. 1. Angel (individual) 05-Mar-2024. $2.5M. Cancelled. Pre-Clinical Trials. To view Hoverink Biotechnologies’s complete valuation … originlab crack version

"WebPresently, Davidra Nicole Sajna holds the position of Chairman for Hoverink Biotechnologies, Inc. Ms. Sajna received an undergraduate degree from Texas State University, an undergraduate degree from... " - Hoverink biotechnologies inc

Hoverink biotechnologies inc

Web10 de nov. de 2024 · Contact: Hoverink Biotechnologies, Inc. 1801 Century Park East., 24th Floor Los Angeles, California [email protected] Web23 de jan. de 2024 · Los Angeles, Jan. 23, 2024 -- Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will be succeeded by Cyrus Sajna as CEO and CFO of the company. ...

Did you know?

WebHoverink Biotechnologies Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 000-54830 46-3590875 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1801 Century Park E., 24th Floor. Los Angeles, California. 90067 Web21 de mai. de 2024 · Our mission is to improve the lives of patients who suffer from rare diseases for which there are... Los Angeles, CA 90067

WebHOVERINK BIOTECHNOLOGIES, INC. EIN# 46-3590875. BOARD OF DIRECTORS RESOLUTION TO GRANT RESTRICTED STOCK GRANT AWARDS TO EXECUTIVES, BOARD MEMBERS AND CONSULTANTS. Upon a duly made, seconded and unanimously adopted consent, the Board of Directors of HOVERINK BIOTECHNOLOGIES, INC … Web28 de abr. de 2024 · LOS ANGELES, CA, April 27, 2024 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it intends to offer, subject to market and other conditions, $2.5 million of Series A Convertible Notes, through a Regulation D 506(b) offering to qualified buyers.

WebHoverink Biotechnologies, Inc. Funding details Hoverink Biotechnologies, Inc. Industry: Pharmaceuticals CIK Number: 0001586494 IRS Number: 463590875 Industry name: … Web23 de jan. de 2024 · Hoverink Biotechnologies, Inc., today announced Hoverink CEO Debbie Carter Steps Down; Cyrus Sajna Appointed as her Successor January 23, 2024, …

Web27 de mar. de 2024 · Hoverink Biotechnologies doesn't have any recent trademark applications, indicating Hoverink Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans. Trademark ...

Web26 de set. de 2024 · CENTURY CITY, CA / ACCESSWIRE / September 26, 2024 / Hoverink Biotechnologies, Inc., today announced thatthey have plans to develop and … how to win every 1v1 in fortniteWeb2 de abr. de 2024 · LOS ANGELES, CA, April 02, 2024 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today that on February 28, 2024, HP White concluded its level II ballistics test for the U.S. Patent pending: BODY GLOBE BODY ARMOR® Serial Number – 87660459 IC 009. how to win every argument en español originlab complex numbersWeb12 de nov. de 2024 · Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic. 12 nov. 2024 14h30 HE Source: Hoverink Biotechnologies, Inc. Overview. LOS ANGELES, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- On September 26, 2024 ... originlab.com/originprolearning.aspxWebCyrus Sajna is Interim CEO/CFO at Hoverink Biotechnologies Inc. See Cyrus Sajna's compensation, career history, education, & memberships. originlab coupon codeWeb5 de jul. de 2024 · LOS ANGELES, CA, July 05, 2024 (GLOBE NEWSWIRE) -- HOVERINK BIOTECHNOLOGIES, seeks to enter into a licensing agreement for the exclusive rights to commercialize LADAVRU(TM) (Dronabinol for injection) and an oral formulation of LADAVRU®. HOVERINK BIOTECHNOLOGIES seeks to partner and receive an up-front … originlab baseline correctionWeb23 de jan. de 2024 · Hoverink Biotechnologies, Inc., today announced Hoverink CEO Debbie Carter Steps Down; Cyrus Sajna Appointed as her Successor [January 23, 2024] Los Angeles, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will be succeeded by … how to win every arena battle in prodigy 2020